BOLDACCELERATOR Trademark

Trademark Overview


On Thursday, April 24, 2025, a trademark application was filed for BOLDACCELERATOR with the United States Patent and Trademark Office. The USPTO has given the BOLDACCELERATOR trademark a serial number of 99154143. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 18, 2025. This trademark is owned by Co-Lab Global, Inc.. The BOLDACCELERATOR trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting, management, and planning services in the field of clinical trials; Business management consulting and advisory services for the clinical trials industry; Business management consultation in the field of clinical trials; Business assistance, advisory and consulting services in the field of clinical trials; Business management and consultation in the field of clinical trials; Business consultation in the field of clinical trials; Business consulting services in the field of clinical trials; Project management for others for business purpose...

Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Designing and developing websites in the field of clinical trials for others; Providing scientific information in the field of clinical trials; Providing scientific research information in the field of clinical trials; Providing information about medical and scientific research; Technical writing in the field of clinical trials
boldaccelerator

General Information


Serial Number99154143
Word MarkBOLDACCELERATOR
Filing DateThursday, April 24, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBOLD ACCELERATOR
Goods and ServicesProviding independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting, management, and planning services in the field of clinical trials; Business management consulting and advisory services for the clinical trials industry; Business management consultation in the field of clinical trials; Business assistance, advisory and consulting services in the field of clinical trials; Business management and consultation in the field of clinical trials; Business consultation in the field of clinical trials; Business consulting services in the field of clinical trials; Project management for others for business purposes in the field of clinical trials; Patient relationship management services; Market analysis and research services; Expert evaluations and reports relating to business matters; Consultancy services regarding business strategies; Development of marketing strategies and concepts; Consultancy regarding advertising communication strategies; Consultancy regarding public relations communication strategies; Marketing and branding services, namely, providing customized communication programs to obtain consumer insights and develop branding strategies; Providing advertising, marketing and promotional services, namely, development of advertising campaigns for clinical trials; Concept and brand development in the clinical trials field; Advertising copywriting
Goods and ServicesConsulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Designing and developing websites in the field of clinical trials for others; Providing scientific information in the field of clinical trials; Providing scientific research information in the field of clinical trials; Providing information about medical and scientific research; Technical writing in the field of clinical trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCo-Lab Global, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009

Trademark Events


Event DateEvent Description
Thursday, April 24, 2025NEW APPLICATION ENTERED
Thursday, April 24, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, September 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 16, 2025ASSIGNED TO EXAMINER
Thursday, September 18, 2025NON-FINAL ACTION E-MAILED
Thursday, September 18, 2025NON-FINAL ACTION WRITTEN
Thursday, September 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED